Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial - Wikidata - awgldk - TriplyDB

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

http://www.wikidata.org/entity/Q34379367

about

The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm Emergent treatments based on the pathophysiology of bipolar disorder: A selective review Animal models of bipolar mania: The past, present and future.How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania.Treatment implications of predominant polarity and the polarity index: a comprehensive review.Pathways to new drug discovery in neuropsychiatry.Novel routes to bipolar disorder drug discovery.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.Review of nutritional supplements for the treatment of bipolar depression.Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies.The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.A potential role for N-acetylcysteine in the management of methamphetamine dependence.Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression.Mitochondrial Agents for Bipolar Disorder.The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence The Staging of Major Mood Disorders: Clinical and Neurobiological Correlates

P2860

Q28066714-3144E5A3-00DC-49AD-9CBF-E6A9271B1977 Q28082445-CE5DE631-457B-4AC8-AAFF-A561E6F4EAC1 Q30357298-56D222E9-8563-4109-81BB-400D26E489E9 Q30453328-6A069CC5-3759-4CF6-8D4B-95D2759D0901 Q34543171-85CD7BB8-0B1F-438F-A44A-01CB5972FB48 Q34649372-2B06B41A-3AE8-4935-B641-63C5A8AC8712 Q35203680-0B779E5C-7EB1-49F6-A25A-6D35446E52A6 Q36594394-98A532F7-07A2-44D9-B5D0-AFBDBAAA1562 Q38109244-A3392EC0-213C-444C-B967-B29FE71C509F Q38125218-485FDBF8-0C84-489F-A3FC-6D4292833196 Q38172469-3BEF5E67-C1B5-401A-869A-E82E33A4B0E7 Q38779572-2DEE0C1D-C55D-4DB9-BADD-4387ABA3F5D9 Q38789179-31F9C330-A680-436E-AF82-1D8AB5A8B3E3 Q42371638-FD672469-F497-42FB-B0D5-4D88EADCB0DE Q47667767-7D5A26C0-BA48-4A81-9934-1DCDC671EEC6 Q48013273-F29455EB-1260-4A34-96CA-8982BC86F48C Q48195966-36217E63-91C5-4CFD-BB82-DAB0C7BD66E2 Q52621890-E7DA73CF-DD59-4C11-9B8F-AB8B485FE956 Q55284097-6FBCBF71-EFAD-49F0-85FD-71E123410FCD Q58698161-5BA09345-60D1-40E9-9373-6F4B82C7A6A7 Q58734855-10B37889-039C-406D-B155-832B10DEAACB

P2860

Maintenance N-acetyl cysteine treatment for bipolar disorder: a double-blind randomized placebo controlled trial

http://www.wikidata.org/entity/Q34379367

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@ast

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@en

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@nl

type

label

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@ast

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@en

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@nl

prefLabel

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@ast

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@en

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@nl

P1433

Q34379367-7B2641FC-BACE-4CFE-827B-3A4E5EB535E0

P1476

Q34379367-F2BA6146-4860-434B-A8D1-4D3397E8C94D

P2093

Q34379367-0001BB49-B62D-4D9D-844D-CAFECBCC0BE1

Q34379367-0DF120F8-8B04-4A07-B545-CB4BDBF03800

Q34379367-2AEAA432-74A1-421E-B454-234DA4437F33

Q34379367-3B3CBFF1-596A-45C3-A0A3-08FC6AA1F4CD

Q34379367-41944AE0-815E-4239-8069-4767327CC22A

Q34379367-5CA9280B-0D83-4DE9-A567-FDE02CDDA483

Q34379367-744E5413-B757-4CAE-9254-7FF032043532

Q34379367-C413242F-2C99-430F-A788-64E1A4E78319

Q34379367-D8FAD1F9-9453-4A61-A5F8-90C5CE731629

Q34379367-DC20F855-5227-4EC0-B51D-6F999AE2753C

P2860

Q34379367-18A1E91C-71FA-4C76-B62F-E910DA12AB16

Q34379367-227BA9CD-C1DB-4197-9476-6992449D20E4

Q34379367-2A3D5916-2BF0-481D-A285-9268F8359B03

Q34379367-2AB200AA-9C7F-4D86-A064-7B81839E2821

Q34379367-49927A25-1DD3-45AF-9956-A67A265E8EB2

Q34379367-527B8EB6-3F79-4AE0-A311-02CE4D618826

Q34379367-53D141DA-E369-4101-8040-930A1ECAD956

Q34379367-5581B6B2-0E24-47E5-A3EF-BFCFB7439B47

Q34379367-5645D6BA-706F-4963-AA30-770B15320900

Q34379367-720E3B84-7FC7-4038-8076-3AD2BEA9508F

P2888

Q34379367-7255181A-0E68-47C0-8803-A7B1E47628FD

P304

Q34379367-6AD2EC58-7A03-4D8E-B82C-A0E130DDFBB9

P31

Q34379367-A254D0A4-8B3D-429F-9695-2F5297DDAA7E

P356

Q34379367-6DD6211B-12D9-45BE-850C-514FD4949869

P407

Q34379367-5C40E349-BA6B-4906-A9CD-9B9E4DC9CDB4

P478

Q34379367-B4FC462E-1E5F-4579-876A-7B7A4B39095D

P50

Q34379367-0ACEB8EB-E267-4841-B537-9080375E7588

Q34379367-31508CC0-85FE-4351-8FF5-E595D5C0E91E

Q34379367-36722B74-AFB5-43F4-ACAD-863B87959604

Q34379367-666E39C2-28CF-4554-AD81-F70113ECBD27

Q34379367-74160FD3-5F1A-43B3-B10F-F23BE2AC6563

Q34379367-BBB79E4D-9B16-483A-B19E-B38A6310CC73

P577

Q34379367-4914ED12-B28B-4036-99AB-E3EEC8B39AA7

P5875

Q34379367-E96EF65D-E270-408C-BC7D-8192801CBE17

P6179

Q34379367-3E06971C-2B8D-4B5D-B8F0-E4C20EB40EDA

P698

Q34379367-F6CCBF97-8921-40BE-8356-571380F887B2

P921

Q34379367-B666E50E-D224-42D6-9DE5-491CA04144E1

Q34379367-B98ABF80-8C7D-4F2B-BB4C-AA6EF8A85580

P932

Q34379367-8F901BEA-F8FD-424D-8A53-767D0795CFC2

P356

1741-7015-10-91

P1433

P1476

Maintenance N-acetyl cysteine ...... mized placebo controlled trial

@en

P2093

Christine Allwang

http://www.w3.org/2001/XMLSchema#string

Gin S Malhi

http://www.w3.org/2001/XMLSchema#string

Heidi Cobb

http://www.w3.org/2001/XMLSchema#string

Ian Schapkaitz

http://www.w3.org/2001/XMLSchema#string

Karen Hewitt

http://www.w3.org/2001/XMLSchema#string

Kirsteen Moss

http://www.w3.org/2001/XMLSchema#string

Kristy Kohlmann

http://www.w3.org/2001/XMLSchema#string

Olivia M Dean

http://www.w3.org/2001/XMLSchema#string

Seetal Dodd

http://www.w3.org/2001/XMLSchema#string

Susan Jeavons

http://www.w3.org/2001/XMLSchema#string

P2860

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

The role of lamotrigine in the management of bipolar disorder

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

A new depression scale designed to be sensitive to change

A rating scale for mania: reliability, validity and sensitivity

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry.

Neuron differentiation and neuritogenesis stimulated by N-acetylcysteine (NAC).

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

P2888

1741-7015-10-91

P304

91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-10-91

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Brisa S. Fernandes

Flávio Kapczinski

Clarissa Severino Gama

P577

2012-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230670243

http://www.w3.org/2001/XMLSchema#string

P6179

1024217420

http://www.w3.org/2001/XMLSchema#string

P698

22891797

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

P932

3482580

http://www.w3.org/2001/XMLSchema#string